Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. for the period between September 2, 2025, and October 31, 2025, due to alleged misleading statements and undisclosed material facts regarding the company's operations and securities trading [1]. Summary by Sections Class Action Announcement - A class action lawsuit has been filed against Picard Medical, Inc. for securities purchased during the specified Class Period [1]. - Investors wishing to serve as lead plaintiffs must file with the Court by April 13, 2026 [1][3]. Compensation Information - Investors who purchased Picard Medical securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Legal Representation - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - Investors have the option to select their own counsel or remain absent from the class at this stage [7]. Details of the Case - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations [5]. - Specific allegations include involvement in a fraudulent stock promotion scheme, insider trading through offshore accounts, and omission of critical information regarding stock price manipulation [5]. Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has a history of representing investors globally [4].
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PMI